Eli Lilly and Company announced that the U.S. FDA has approved Taltz® (ixekizumab) injection 80 mg/mL for the treatment of...
Read moreUse of Sanofi’s dengue vaccine, the world’s first approved shot against the mosquito-borne virus, is to be strictly limited due...
Read moreKyowa Hakko Kirin Co., Ltd. (Tokyo: 4151 President and CEO: Nobuo Hanai; announces the submission of a supplemental application to...
Read moreDaiichi Sankyo Company, Limited announced that its Board of Directors approved a resolution to convert Daiichi Sankyo’s consolidated subsidiary, Kitasato...
Read moreAllergan plc , a leading global pharmaceutical company, is pleased to announce that its manuscript, "Fluctuations in Episodic and Chronic...
Read moreCapricor Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to...
Read moreDaiichi Sankyo Company, Limited announced that it has launched its oral anticoagulant LixianaⓇ OD Tablets 15 mg, 30 mg and...
Read moreMerck , known as MSD outside the United States and Canada announced that the U.S. FDA has approved ISENTRESS® (raltegravir),...
Read moreStealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced that the U.S. Food and...
Read moreBristol-Myers Squibb Company and LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences and biotech startups, announced...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.